| Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B (NCT00926757) | Taipei Veterans General Hospital, Taiwan | 2009-04-01 |
| Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. (NCT00871741) | GlaxoSmithKline | 2009-04-01 |
| Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients (NCT00782301) | ViiV Healthcare | 2009-03-01 |
| Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine (NCT00877357) | Shantha Biotechnics Limited | 2009-01-01 |
| Optimization of Antiviral Therapy of Chronic HBV Infection (NCT01623778) | Changhai Hospital | 2009-01-01 |
| Sonazoid Enhanced Liver Cancer Trial for Early Detection (NCT00822991) | Kindai University | 2009-01-01 |
| Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine (NCT00805389) | GlaxoSmithKline | 2008-12-15 |
| Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. (NCT00774995) | GlaxoSmithKline | 2008-11-01 |
| Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine (NCT02152709) | Jiangsu Province Centers for Disease Control and Prevention | 2008-11-01 |
| Hepatitis B and HIV Co-Infection in Patients in Uganda (NCT00782158) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-27 |
| A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA (NCT00693186) | Sanofi Pasteur, a Sanofi Company | 2008-10-01 |
| Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants (NCT00753649) | GlaxoSmithKline | 2008-09-23 |
| Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine (NCT00737568) | Gilead Sciences | 2008-09-01 |
| Hepatitis B Acceptability and Vaccination Incentive Trial (NCT00744289) | Kirby Institute | 2008-09-01 |
| Antigen-specific Immune Response to Hepatitis B Virus in Utero (NCT00845403) | National University Hospital, Singapore | 2008-09-01 |
| A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B (NCT00753467) | Huntington Medical Research Institutes | 2008-09-01 |
| Genetic Analysis of Liver Cancer (NCT00768001) | Samuel So | 2008-06-01 |
| Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) (NCT00670839) | ANRS, Emerging Infectious Diseases | 2008-05-01 |
| Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants (NCT00831753) | Sanofi Pasteur, a Sanofi Company | 2008-05-01 |
| Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders (NCT00704106) | Pacific Health Foundation | 2008-05-01 |
| Investigation of Hepatitis B and Hepatitis C in Taiwan (NCT00946010) | National Taiwan University Hospital | 2008-04-01 |
| Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection (NCT00662545) | University of California, San Francisco | 2008-04-01 |
| Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ (NCT00654901) | Sanofi Pasteur, a Sanofi Company | 2008-03-01 |
| Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir (NCT01046799) | HepNet Study House, German Liverfoundation | 2008-03-01 |
| Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine (NCT00617812) | Shantha Biotechnics Limited | 2008-03-01 |
| Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine (NCT00674908) | Shantha Biotechnics Limited | 2008-03-01 |
| Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children (NCT00611559) | GlaxoSmithKline | 2008-02-14 |
| Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients (NCT00722332) | Cangene Corporation | 2008-02-01 |
| Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine (NCT00627458) | GlaxoSmithKline | 2008-02-01 |
| Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV) (NCT01574521) | YiYang Zhu | 2008-01-01 |
| Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule (NCT00480116) | Henogen | 2008-01-01 |
| Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants (NCT00619502) | Sanofi Pasteur, a Sanofi Company | 2007-12-01 |
| Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine (NCT00524576) | GlaxoSmithKline | 2007-11-28 |
| Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults (NCT00702663) | Far Eastern Memorial Hospital | 2007-10-01 |
| Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants (NCT00514709) | Sanofi Pasteur, a Sanofi Company | 2007-09-01 |
| Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ (NCT00534833) | Sanofi Pasteur, a Sanofi Company | 2007-09-01 |
| Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B (NCT00524173) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2007-08-29 |
| The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines (NCT00792610) | National Taiwan University Hospital | 2007-08-01 |
| Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus (NCT00496158) | Pharmasset | 2007-08-01 |
| Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus (NCT00496002) | Pharmasset | 2007-08-01 |
| A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease (NCT00498212) | Dynavax Technologies Corporation | 2007-07-01 |
| Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine (NCT00511095) | Dynavax Technologies Corporation | 2007-06-01 |
| Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV (NCT00501124) | Bukwang Pharmaceutical | 2007-05-01 |
| Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines (NCT00463437) | GlaxoSmithKline | 2007-04-25 |
| Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine. (NCT00456625) | GlaxoSmithKline | 2007-04-01 |
| Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 (NCT00451984) | Aalborg University Hospital | 2007-03-01 |
| Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™ (NCT00445185) | Henogen | 2007-03-01 |
| Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease (NCT00932269) | Swedish Institute for Infectious Disease Control | 2007-03-01 |
| Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) (NCT00432042) | Merck Sharp & Dohme LLC | 2007-01-12 |
| Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients (NCT00391638) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-01-01 |
| Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone (NCT00376259) | Novartis | 2007-01-01 |
| Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients (NCT02108444) | Peking University | 2007-01-01 |
| Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma (NCT00629486) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2007-01-01 |
| Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine (NCT00435812) | Dynavax Technologies Corporation | 2006-12-01 |
| Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B (NCT00412529) | Novartis Pharmaceuticals | 2006-12-01 |
| Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED) (NCT00441012) | Merck Sharp & Dohme LLC | 2006-12-01 |
| Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge (NCT00411697) | GlaxoSmithKline | 2006-12-01 |
| Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) (NCT00412750) | Novartis | 2006-12-01 |
| Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants (NCT00404651) | Sanofi Pasteur, a Sanofi Company | 2006-11-01 |
| The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines (NCT01203319) | Jiangsu Province Centers for Disease Control and Prevention | 2006-11-01 |
| Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED) (NCT00440531) | Merck Sharp & Dohme LLC | 2006-11-01 |
| Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging (NCT00401336) | Rennes University Hospital | 2006-11-01 |
| A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057) (NCT00414050) | Merck Sharp & Dohme LLC | 2006-10-06 |
| Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age (NCT00376779) | GlaxoSmithKline | 2006-10-01 |
| Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants (NCT00401531) | Sanofi Pasteur, a Sanofi Company | 2006-10-01 |
| Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) (NCT00393523) | Merck Sharp & Dohme LLC | 2006-09-01 |
| Increasing Hepatitis B Screening Among Korean Church Attendees (NCT00760721) | University of California, Los Angeles | 2006-09-01 |
| Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients (NCT00881036) | Kyoto University | 2006-08-01 |
| Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection (NCT00362635) | Bukwang Pharmaceutical | 2006-08-01 |
| Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV (NCT00362336) | Sanofi Pasteur, a Sanofi Company | 2006-08-01 |
| Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine (NCT00343889) | Sanofi Pasteur, a Sanofi Company | 2006-08-01 |
| Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® (NCT00362427) | Sanofi Pasteur, a Sanofi Company | 2006-08-01 |
| Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib (NCT00356564) | GlaxoSmithKline | 2006-07-01 |
| Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule (NCT00315055) | Sanofi Pasteur, a Sanofi Company | 2006-07-01 |
| Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. (NCT00313911) | Sanofi Pasteur, a Sanofi Company | 2006-07-01 |
| The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma (NCT00720668) | Sun Yat-sen University | 2006-06-01 |
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection (NCT01018381) | The 108 Military Central Hospital | 2006-06-01 |
| Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants (NCT00348881) | Sanofi Pasteur, a Sanofi Company | 2006-06-01 |
| Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib (NCT00335881) | GlaxoSmithKline | 2006-06-01 |
| Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine (NCT00329576) | GlaxoSmithKline | 2006-05-01 |
| ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency (NCT00493506) | Health Enhancement Products, Inc. | 2006-05-01 |
| Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants (NCT00320463) | GlaxoSmithKline | 2006-04-01 |
| A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults (NCT04531098) | VBI Vaccines Inc. | 2006-03-02 |
| Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. (NCT00316680) | GlaxoSmithKline | 2006-03-01 |
| Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination (NCT00291954) | Henogen | 2006-03-01 |
| A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody. (NCT00291980) | Henogen | 2006-03-01 |
| A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. (NCT00291941) | Henogen | 2006-02-01 |
| Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants (NCT00197275) | GlaxoSmithKline | 2006-02-01 |
| Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants (NCT00303316) | Sanofi | 2006-02-01 |
| Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients (NCT00426712) | Dynavax Technologies Corporation | 2006-01-01 |
| Pentavalent DTaP-Hep B-IPV (NCT00133445) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules (NCT00316147) | GlaxoSmithKline | 2005-12-01 |
| Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 (NCT00307567) | GlaxoSmithKline | 2005-11-01 |
| Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 (NCT00142740) | University of North Carolina, Chapel Hill | 2005-10-01 |
| Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants (NCT00158756) | GlaxoSmithKline | 2005-09-12 |
| Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers (NCT02153320) | GlaxoSmithKline | 2005-09-05 |
| Risk Assessment of Long-Haul Truck Drivers (NCT00381992) | Wake Forest University Health Sciences | 2005-09-01 |
| Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation (NCT00147459) | National Taiwan University Hospital | 2005-09-01 |
| Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) (NCT00120796) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-08-01 |
| Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator (NCT00175435) | University of British Columbia | 2005-08-01 |